Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Rocci

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Expert Review of Molecular Diagnostics|May 14, 2015
MET/HGF pathway in multiple myeloma: from diagnosis to targeted therapy?Manuela Gambella, Antonio Palumbo, Alberto Rocci
Expert Review of Molecular Diagnostics|August 8, 2014
The potential of miRNAs as biomarkers for multiple myelomaAlberto Rocci, Craig C Hofmeister, Flavia Pichiorri
British Journal of Haematology|November 20, 2018
Venous thromboembolism in multiple myeloma - choice of prophylaxis, role of direct oral anticoagulants and special considerationsDawn Swan, Alberto Rocci, Charlotte Bradbury, et al.
JACC. Case Reports|July 28, 2021
Evaluating Suspected Cardiac AmyloidosisManish Motwani, Parthiban Arumugam, Alberto Rocci, et al.
Pediatric Blood & Cancer|July 27, 2010
Compound heterozygosity for two new TERT mutations in a patient with aplastic anemiaAnna Aspesi, Stefano Vallero, Alberto Rocci, et al.
Pediatric Blood & Cancer|June 3, 2009
Analysis of telomeres in peripheral blood cells from patients with bone marrow failureElisa Pavesi, Federica Avondo, Anna Aspesi, et al.
British Journal of Haematology|April 10, 2013
High expression of cereblon (CRBN) is associated with improved clinical response in patients with multiple myeloma treated with lenalidomide and dexamethasoneDaniel Heintel, Alberto Rocci, Heinz Ludwig, et al.
Plos One|May 11, 2023
RWD-derived response in multiple myelomaTao Xu, James Roose, Mellissa Williamson, et al.
Haematologica|February 6, 2014
High XBP1 expression is a marker of better outcome in multiple myeloma patients treated with bortezomibManuela Gambella, Alberto Rocci, Roberto Passera, et al.
American Journal of Hematology|September 29, 2011
Overexpression of HOXB7 and homeobox genes characterizes multiple myeloma patients lacking the major primary immunoglobulin heavy chain locus translocationsLuca Agnelli, Paola Storti, Katia Todoerti, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Expert Review of Molecular Diagnostics|May 14, 2015
MET/HGF pathway in multiple myeloma: from diagnosis to targeted therapy?Manuela Gambella, Antonio Palumbo, Alberto Rocci
Expert Review of Molecular Diagnostics|August 8, 2014
The potential of miRNAs as biomarkers for multiple myelomaAlberto Rocci, Craig C Hofmeister, Flavia Pichiorri
British Journal of Haematology|November 20, 2018
Venous thromboembolism in multiple myeloma - choice of prophylaxis, role of direct oral anticoagulants and special considerationsDawn Swan, Alberto Rocci, Charlotte Bradbury, et al.
JACC. Case Reports|July 28, 2021
Evaluating Suspected Cardiac AmyloidosisManish Motwani, Parthiban Arumugam, Alberto Rocci, et al.
Pediatric Blood & Cancer|July 27, 2010
Compound heterozygosity for two new TERT mutations in a patient with aplastic anemiaAnna Aspesi, Stefano Vallero, Alberto Rocci, et al.
Pediatric Blood & Cancer|June 3, 2009
Analysis of telomeres in peripheral blood cells from patients with bone marrow failureElisa Pavesi, Federica Avondo, Anna Aspesi, et al.
British Journal of Haematology|April 10, 2013
High expression of cereblon (CRBN) is associated with improved clinical response in patients with multiple myeloma treated with lenalidomide and dexamethasoneDaniel Heintel, Alberto Rocci, Heinz Ludwig, et al.
Plos One|May 11, 2023
RWD-derived response in multiple myelomaTao Xu, James Roose, Mellissa Williamson, et al.
Haematologica|February 6, 2014
High XBP1 expression is a marker of better outcome in multiple myeloma patients treated with bortezomibManuela Gambella, Alberto Rocci, Roberto Passera, et al.
American Journal of Hematology|September 29, 2011
Overexpression of HOXB7 and homeobox genes characterizes multiple myeloma patients lacking the major primary immunoglobulin heavy chain locus translocationsLuca Agnelli, Paola Storti, Katia Todoerti, et al.
Pageof 4